Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-04

Clinical Trial Update: A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women [Phase 3]

View source ↗

Summary

Phase III randomized trial evaluating topical 5-fluorouracil maintenance therapy versus observation for high-grade cervical dysplasia in HIV-infected women; stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topical vaginal fluorouracil (5-fluorouracil, 5-FU) (5-fluorouracil)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Cervix, Dysplasia | Phase 3 | Status: COMPLETED